3,3’-((3,4,5-trifluoropHenyl)methylene)bis(4-hydroxy-2H-chromen-2-one) inhibit lung cancer cell proliferation and migration
PLOS ONE · 22.05.2024 · 19 (5) · e0303186
DOI: 10.1371/journal.pone.0303186 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 22.05.2024. Verfasst von Wenhui Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Foshan University, Foshan, Guangdong Province, PR China. Hauptthemen laut MEDLINE: Cell Movement, Cell Proliferation, Lung Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Science and Technology Key Project of COVID‑19 in Foshan city, Regional Joint Fund‑Key Project of Guangdong Basic and Applied Basic Research fund, the Provincial Enterprise Joint Fund General Project of Guangdong Basic and Applied Basic Research fund.
Abstract (Originalsprache)
Lung cancer is a major public health challenge and, despite therapeutic improvements, is the first leading cause of cancer worldwide. The current cure rate from advanced cancer treatment is excessively low. Therefore, it is of great importance to identify novel, potent and less toxic anticancer agents for the treatment of lung cancer. The aim of our research is to synthesize a new biscoumarin 3,3’-((3,4,5-trifluorop -phenyl)methylene)bis(4-hydroxy-2H-chromen-2-one) (C35) as an anticancer agent. C35 was simply prepared by 4-hydroxycoumarin and 3,4,5-trifluorobenzaldehyde under ethanol and its structure was analyzed by spectroscopic analyses. The anti-proliferation effect of C35 was detected using CCK-8 assay. Migration abilities were measured by Transwell assay. The expression of correlated proteins was determined by Western blot. The results showed that C35 displayed strong cytostatic effects on lung cancer cell proliferation. In addition, C35 possessed a significant inhibition of migration by reducing the expression of matrix metalloproteinases-2 (MMP-2) and MMP-9 in lung cancer cells. Furthermore, C35 treatment suppressed the phosphorylation of p38 in lung cancer cells. Moreover, in vivo experiments were carried out, in which we treated Lewis tumor-bearing C57 mice via intraperitoneal injection of C35. Results showed that C35 inhibited tumor growth in vivo. In conclusion, our study demonstrated the anticancer activity of C35 via suppression of lung cancer cell proliferation and migration, which is possibly involved with the inhibition of the p38 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Medicine, Foshan University, Foshan, Guangdong Province, PR China.
- Guangdong Provincial Key Laboratory of Traditional Chinese Medicine Formula Granule, Guangdong Yifang Pharmaceutical Co., Ltd., Foshan, Guangdong Province, PR China.
- College of Traditional Chinese Medicine, Guangdong Pharmacuetical University, Guangzhou, Guangdong Province, PR China.
ORCID-Profile: Ruixue Wang
Förderung
- The Science and Technology Key Project of COVID‑19 in Foshan city
- Regional Joint Fund‑Key Project of Guangdong Basic and Applied Basic Research fund
- the Provincial Enterprise Joint Fund General Project of Guangdong Basic and Applied Basic Research fund
- the Special Fund for Key Fields of Higher Education of Guangdong Province
- the project of the Scientific and Technological Office of Foshan
Zitieren
APA
Luo, W., Chang, G., Lin, D., Xie, H., Sun, H., Li, Z., Mo, S., Wang, R., Wang, Y., & Zheng, Z. (2024). 3,3’-((3,4,5-trifluoropHenyl)methylene)bis(4-hydroxy-2H-chromen-2-one) inhibit lung cancer cell proliferation and migration. PLOS ONE, 19(5), e0303186. https://doi.org/10.1371/journal.pone.0303186
Vancouver
Luo W, Chang G, Lin D, Xie H, Sun H, Li Z, et al. 3,3’-((3,4,5-trifluoropHenyl)methylene)bis(4-hydroxy-2H-chromen-2-one) inhibit lung cancer cell proliferation and migration. PLOS ONE. 2024;19(5):e0303186. doi:10.1371/journal.pone.0303186
BibTeX
@article{Luo2024,
author = {Luo, Wenhui and Chang, Guoxin and Lin, Dingmei and Xie, Hongyi and Sun, Huilong and Li, Zhibin and Mo, Shirong and Wang, Ruixue and Wang, Yan and Zheng, Zhaoguang},
title = {3,3’-((3,4,5-trifluoropHenyl)methylene)bis(4-hydroxy-2H-chromen-2-one) inhibit lung cancer cell proliferation and migration},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {5},
pages = {e0303186},
doi = {10.1371/journal.pone.0303186}
}
EUVIMED